CN1091290A - The pharmaceutical composition that contains aminoglycoside antibiotic that is suitable for local application - Google Patents

Abstract

Be suitable for the pharmaceutical composition of local application, the active component that contains is an antibiotics, and this antibiotics belongs to aminoglycoside, optionally also contains other material and other antibiotics of the skin surface rehabilitation that can promote damage.

The serious case of this combination agent proof treatment as damage of lower limb ulcer and/or decubital ulcer, is effective.

Description

The pharmaceutical composition that contains aminoglycoside antibiotic that is suitable for local application

The activity of aminoglycoside and mechanism of action have been well-known, and clearly are owing to formed the albumen that highly stable key suppressed microorganism synthesize between antibiotics and ribosomal attack site.In aminoglycoside, particularly the ammonia Ka-7038 has a broad effect spectrum external, comprises multiple microorganism, or gram positive bacteria, or gram negative bacteria, for example staphylococcus aureus comprises that producing penicillinase shows the drug-fast bacterial strain of methicillinum; Escherichia coli; Pneumobacillus; Bacillus pyocyaneus; Positive and negative indolo Bacillus proteus; The stuartii Providence; Salmonella s.p.p; Lao He bacterium s.p.p; Acinetobacter calcoaceticus.The ammonia Ka-7038 is not made most of enzymatic degradation of aminoglycoside inactivation by other; Here it is why the microorganism of anti-gentamycin, tobramycin and kanamycin on the contrary to the reason of ammonia Ka-7038 sensitivity.

Up to the present the unique route of administration and the therapeutic use of aminoglycoside are that intramuscular and/or intravenous are by injection or perfusion aqueous buffer solution.

So treat the long-lasting infection that is caused by the aminoglycoside sensitive strain, patient must accept one or more drug administration by injection cycles, and treatment burn and top layer and/or skin deteriorated blood phenomenon also are like this.

But, being administered systemically of aminoglycoside comprises that do not expect and very important side effect, generally all is higher than with dosage or administration time is longer than specified degree and is interrelated.Particularly in the situation of ammonia Ka-7038, may notice on the 8th correct neural level toxicity (particularly ototoxicity) to occur, comprise that tinnitus, dizziness, dysecoia, Toxicity of Kidney add the albumen urea, have leukocyte and erythrocyte, high blood nitrogen and oliguria in sedimentary color comparison tube.These data also appear in the catalogue of Italian Ministry of Public Health definition.

The applicant finds, uses aminoglycoside by local skin, and is very long-acting and can reach the excellent treatment effect, any above-mentioned side effect do not occur.So the present invention relates to use the aminoglycoside antibiotic preparation to be suitable for the pharmaceutical composition of local application, comprise excipient and additive that can be medicinal and random various antibiotics, and active component, they can promote the skin surface rehabilitation that damages.

Pharmaceutical composition local skin of the present invention administration during in order to treatment table shallow skin infection, ulcer of the lower limb and decubital ulcer, proves special efficacy.

Contain characteristic and the advantage of aminoglycoside antibiotic of the present invention as the compositions of active component, available following detailed is illustrated better.

In aminoglycoside antibiotic, be excellent with ammonia Ka-7038, kanamycin, polygynax, paromomycin, tobramycin, sisomicin, ethyl west acidomycin sulfate, dibekacin B, clindamycin and lincomycin.

The antibiotics that other is relevant with aminoglycoside also can be used for compositions of the present invention, for example erythromycin, their salt or derivant, and neomycin.

The amount of the contained aminoglycoside active component of compositions of the present invention be 0.1 and 20%(b.w) between, be preferably in 1 and 10%(b.w) between.Reactive compound can suitably be filled a prescription by excipient, adjuvant, short adsorbent or the like mode, as long as they can be medicinal.

The example of this class excipient has:

Oil excipient, for example fat, vegetable oil, cocoa butter, Brazil wax, spermaceti, mineral coagulant, silicone;

Absorption additives, for example agnolin and high fatty alcohol;

Emulsifying and/or water solublity additives, for example glycerol, propylene glycol, polypropylene glycol, tragakanta and pectin.

Can also use in the prescription natural, synthetic or semisynthetic polymer, for example cellulose and derivant thereof, hydroxyethyl-cellulose, hydroxypropyl-methylcellulose, carboxy vinyl polymer, polyvinyl alcohol or the like.

The percent that these materials exist depends on their different molecular weight and different viscosity, and viscosity can show by aqueous and/or alcohol solution or dispersion liquid.

Can also use other material in the prescription, lytic agent for example, buffer agent, antibacterial and antiseptic, or arbitrarily use spice, volatile oil, stain or the like, depend primarily on the special target that product and/or same recipe are optimized.

Be clear that very that in addition other material then can be added in the prescription or replaces aforementioned substances fully so long as pharmaceutical technology and technology are known.

Though should be appreciated that and do not describe all these prescriptions here especially, they all are among aim of the present invention and the scope.

Compositions of the present invention for example mechanically is incorporated into active component in the excipient substrate by modes such as fusion or emulsifyings according to the known technology preparation of document.

Described compositions can be made gel or Emulsion, pomade, lotion, ointment, paste, Gauze mask with medicine, cream, transfer system, absorbent gauze.

This compositions can arbitrarily contain other active component that shows complementary activity, for example resemble the material that is suitable for promoting the skin surface rehabilitation that damages, or any other useful material, for example antiseptic, local anesthetic, collagen, hyaluronic acid and sodium salt, dermatan sulfate, sulphuric acid ointment element, heparinoid chemical compound or the like.

Compare with injecting drug use, local extremely beneficial with the aminoglycoside antibiotic proof, the side effect that strong reduction is not expected, and reach the high concentration of medicine in the one part.Described route of administration treatment top layer skin infection, ulcer of the lower limb and decubital ulcer proof are effective especially.

The embodiment that provides below only is in order to describe, and does not limit any spirit of the present invention and scope.

Embodiment 1

Ammonia Ka-7038 hydrophilic gel (2.5%)

The glue of preparation has following composition:

The ammonium sulphate Ka-7038: corresponding to the amount 2.5g of ammonia Ka-7038,

P-Hydroxybenzoate 0.06g

Propyl p-hydroxybenzoate 0.03g

Hydroxyethyl-cellulose (Natrosol 250 HHT-Hercules) 2.50g

Ethanol 2.00g

Distilled water 88.41g

During preparation, antiseptic is dissolved in the ethanol, and hydroxyethyl-cellulose bit by bit adds, and then adds a small amount of distilled water.Under slowly stirring, make hydroxyethyl-cellulose hydration number hour.

The ammonium sulphate Ka-7038 dissolves in the distilled water, and solution is added in the suspension that obtains in advance; The mixture that obtains transfers to final volume with distilled water, and keeps stirring, and is mixed into suitable semisolid systems, and the transparent adhesive tape that obtains like this pours into aluminum matter pipe.

Can also in prescription, use buffer agent, and the best pH that obtains being suitable for preparation, the stability of the product of raising preparation.

Embodiment 2

Ammonia Ka-7038 hydrophilic gel (5%)

The glue of preparation has following composition:

The ammonium sulphate Ka-7038: corresponding to the amount 5.0g of ammonia Ka-7038,

P-Hydroxybenzoate 0.06g

Propyl p-hydroxybenzoate 0.03g

Hydroxyethyl-cellulose (Natrosol 250 HHT-Hercules) 2.50g

Ethanol 2.00g

Distilled water 88.91g

The preparation condition of said preparation is with embodiment 1.

Embodiment 3

Ammonia Ka-7038 hydrophilic gel (5%)

The glue of preparation has following composition:

The ammonium sulphate Ka-7038: corresponding to the amount 5.0g of ammonia Ka-7038,

P-Hydroxybenzoate 0.502g

Propyl p-hydroxybenzoate 0.132g

Hydroxyethyl-cellulose (Natrosol 250 HHT-Hercules) 2.50g

Solution with sulphuric acid water is transferred pH4.5g

Distilled water adds to 100g

50% of about required water is added in preparation process in the suitable semi-solid mixtures, adds hydroxyethyl-cellulose, the mixture that obtains aquation 3 hours under slowly stirring.

Add the solution of ammonium sulphate Ka-7038, sodium bisulfite and the sodium citrate of preparation respectively then.

Make pH control to 4.5-5.0 by adding dilute sulfuric acid.

Continue to mix, the semi-transparent gelatin that obtains like this pours in the aluminum platinotrom.

Embodiment 4

The absorbent gauze of ammonia Ka-7038 and collagen

Prepare aseptic absorbent gauze with following component:

Ammonium sulphate Ka-7038: corresponding to ammonia Ka-7038 amount 1.00g

Liquid collagen 2.0g

The ammonium sulphate Ka-7038 dissolves in aqueous buffer solution, makes pH value be transferred to 4.5.

Collagen dissolves in physiological solution respectively; Filter then (with 0.8 μ m filter).The solution that obtains is added to ammonia Ka-7038 solution, checks pH(and can transfer to 4.5 sometimes), filter (in addition also can with the filter of 0.45 μ m) with 0.22 μ m funnel at last.

The solution that obtains is evenly distributed on the gauze carrier, carries out lyophilization then.

According to known fabrication techniques, can obtain absorbent gauze, this gauze can be sterilized by well-established law, or directly obtains as form with aseptic, finishes processing technology according to the known technical guarantee (aseptic cabinet) under aseptic condition of document.

The evaluation of therapeutic activity

Experimental work 180 suffer from the ulcer of the lower limb sexuality dye (because various etiology, for example by diabetes, hypertension, tremulous pulse illness or mix disease and cause) or suffer from surface infection (from pus) or suffer among the patient that decubital ulcer infects and carrying out.

Before beginning test, each patient checks comprehensively, comprises damage inspection, particularly the state at Infection Status and ulcer surface and edge; And collect some materials from ulcer surface with swab, so that finish identical microbiological examination and anti-microbial test.Further estimate patient's symptomatology, for example pain degree.Random table is two experimental grouies with patient's part then.Test group is pressed following composition:

Use the ammonia Ka-7038 hydrophilic gel treatment group of embodiment 2:

90 patients, 49 men and 41 women, age 29 and 83 years old between, mean age is 58.41 ± 11.63, the surface damage that demonstration is caused by ammonia Ka-7038 sensitive strain (28 patients), decubital ulcer (25 patients), lower limb ischemic ulcer (17 patients), veins of lower extremity ulcer (15 patients), lower limb mixed sore (5 patients).

These patients treat with ammonia Ka-7038 (5%) hydrophilic gel, and dosage is 500mg ammonia Ka-7038, and every day twice, treatment time is 7 days to 15 days (average=11.21 ± 5.14).

Ammonia Ka-7038 treatment group

90 patients, 40 male and 50 women, age 33 and 86 years old between, mean age=61.55 ± 10.71, the shallow infection of table (28 patients), lower limb ischemic ulcer (23 patients), veins of lower extremity ulcer (17 patients), the lower limb mixed sore (3 patients) of demonstration decubital ulcer.

The ammonia Ka-7038 that the patient uses contains 1g ammonia Ka-7038 for 1 bottle, and dosage is each 1 bottle, and every day twice, treatment time is 9 to 15 days (the mean treatment time is 14.63 ± 2.86 days).

In order to estimate therapeutic activity, the variable spot that is directly proportional with intensity is designated as pain and infection symptoms, simultaneously to the state of ulcer surface, the re-epithelialization degree at the edge of same ulcer is carried out the evaluation of class.When treatment finishes, represent the clinical effectiveness of gathering with activity and persistent period and possible side effect.

Clinical experiment work points out that combination agent of the present invention has the active and outstanding persistent period of good curing.

Use the colloid of ammonia Ka-7038, the obvious effective rate of 75-80% is arranged, make from the cultivation of the swab of ulcer surface and turn out cloudy, make the rapid re-epithelialization of wound surface.

Also obtained similar results with ammonia Ka-7038 bottle treatment, the special medicine persistent period of combination agent of the present invention meaningfully, and never observe the side effect of part or system.Resistance attitude activity rating to the healthy volunteer:

In 24 healthy volunteers, carried out resistance attitude activity rating, the age 18 and 53 years old between (30 years old mean age), comprise 10 women and 14 male, treat with the ammonia Ka-7038 of embodiment 2.

The experimenter accepts patch test (a kind of biological diagnosis) and sensitization patch test (sensitization biological diagnosis).

In first kind of situation, test according to usual way, contacting 24-96 hour should measure; In second kind of evaluation, be exposed to then under the irradiation under ultraviolet ray, measure after 24 hours.Ametaboly and/or allergic phenomena in experimentation.

Because 5% ammonia Ka-7038 glue does not produce any positively charged dermoreaction to 24 health volunteers, show that it has good applicability in abnormal case, consider character and pharmacology feature that the ammonia Ka-7038 shows, confirmation is in the Comprehensive Treatment of the ulcerative lesions of a variety of causes, and it has primary importance.

Claims (13)

1, use the aminoglycoside antibiotic preparation to be suitable for the pharmaceutical composition of local application, it comprises treatment upward acceptable excipient and additives and random active component, this active component can promote the skin surface rehabilitation that damages, and it also comprises other antibiotics.

2, according to the application of claim 1, feature is that said aminoglycoside antibiotic is ammonia Ka-7038, kanamycin, framycetin, paromomycin, tobramycin, sisomicin, netilmicin sulfate, dibekacin B, clindamycin and lincomycin.

3, according to the application of claim 1, feature is that said compositions contains 0.1% to 20%b.w. aminoglycoside antibiotic.

4, according to the application of claim 1, feature is that said compositions contains 1% to 10% aminoglycoside antibiotic.

5, according to the application of claim 1, feature be said excipient and additives from fat, vegetable oil, cocoa butter, Brazil wax, spermaceti, mineral coagulant, silicone, lanoline, high fatty alcohol, glycerol, propylene glycol, Polyethylene Glycol, tragakanta, select in the pectin.

6, according to the application of claim 1, feature be the active component of the said skin surface rehabilitation that can promote damage from collagen, hyaluronic acid and sodium salt thereof, select in chondroitin sulfate B and the chondroitin sulfate.

7, the pharmaceutical composition that is suitable for local application, said composition comprise acceptable excipient and additives in aminoglycoside antibiotic, the treatment and the active component of the skin surface rehabilitation that can promote to damage, and other antibiotics.

8, according to the compositions of claim 7, feature is that said aminoglycoside antibiotic is ammonia Ka-7038, kanamycin, framycetin, paromomycin, tobramycin, sisomicin, netilmicin, dibekacin B, clindamycin and lincomycin.

9, according to the compositions of claim 7, feature is said aminoglycoside antibiotic content 0.1% and 20%b.w.

10, according to the compositions of claim 7, feature is to select from fat, vegetable oil, cocoa butter, Brazil wax, spermaceti, mineral coagulant, silicone, lanoline, high fatty alcohol, glycerol, propylene glycol, Polyethylene Glycol, tragakanta, pectin at said excipient and additives.

11, according to the compositions of claim 7, feature is to promote the active component of the skin surface rehabilitation that damages to select from collagen, hyaluronic acid and sodium salt thereof, chondroitin sulfate B and chondroitin sulfate.

12, according to the compositions of claim 7, feature is that other antibiotics is erythromycin, and derivant or salt, and neomycin.

13, according to the compositions of claim 7, feature is that they are prepared into gel, Emulsion, pomade, lotion, ointment, paste, absorbent gauze.